Timing of invasive treatment after fibrinolysis in ST elevation myocardial infarction - A meta-analysis of immediate or early routine versus deferred or ischemia-guided randomised controlled trials

Steffen Desch, Ingo Eitel, Kazem Rahimi, Suzanne De Waha, Gerhard Schuler, Holger Thiele*

*Corresponding author for this work
20 Citations (Scopus)


Context: Controversy remains over the optimal timing of percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) who have initially been treated with fibrinolytic agents. Objective: A meta-analysis of studies was performed comparing immediate or early angiography after fibrinolysis versus a more conservative strategy of deferred PCI or ischaemia-guided management. Data sources: MEDLINE, EMBASE, CENTRAL, ClinicalTrials.gov Study selection: Nine contemporary randomised controlled trials eligible for inclusion enrolling a total of 3325 patients were identified. Follow-up ranged between 1 and 12 months. Data extraction: Data were extracted by two independent reviewers using a standard form and cross-checked. Results: There was suggestive evidence for a reduction in the risk of total mortality in patients undergoing immediate or early PCI. There were no significant differences in the risk of stroke or major bleeding. Conclusions: These results support the current recommendation of a routine early invasive strategy in STEMI patients after successful fibrinolysis.

Original languageEnglish
Issue number21
Pages (from-to)1695-1702
Number of pages8
Publication statusPublished - 11.2010

Research Areas and Centers

  • Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

  • 205-12 Cardiology, Angiology

Cite this